T cells

Vineti introduces new PTM® Integration Suite: purpose-built connectivity and interoperability for cell and gene therapies

Vineti, developer of the leading digital platform of record for personalized therapeutics, today announced a new Integration Suite as a cornerstone of its Personalized Therapy Management® (PTM) solution. This API-based PTM® Integration Suite delivers purpose-built connectivity for orchestrating cell and gene therapy systems, ultimately speeding and simplifying workflows and providing better care for patients..

Read More
April 30, 2019

Q1 update from Vineti

As 2019 shapes up to be yet another landmark year for advanced therapies, Vineti is hard at work on our...

April 24, 2019

Supply chain management readiness, Part 1: strategy

There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....

April 23, 2019

Cell therapy labels that work — pointers to keep your patient and your product in sync

In cell therapy, smarter labeling means greater safety and speed. If you’re a cell therapy developer, you have a make-or-break...

April 23, 2019

Setting standards — three essential starting points

Welcome to the Vineti blog! This is our first post, and we’re looking forward to sharing insights, perspectives and company updates here....